AAAAAA
Results:
1-25
|
Results: 25
Authors:
Horsman, DE
Connors, JM
Pantzar, T
Gascoyne, RD
Citation: De. Horsman et al., Analysis of secondary chromosomal alterations in 165 cases of follicular lymphoma with t(14;18), GENE CHROM, 30(4), 2001, pp. 375-382
Authors:
Anderson, GM
Connors, JM
Hardy, SL
Valent, M
Goodman, RL
Citation: Gm. Anderson et al., Oestradiol microimplants in the ventromedial preoptic area inhibit secretion of luteinizing hormone via dopamine neurones in anoestrous ewes, J NEUROENDO, 13(12), 2001, pp. 1051-1058
Authors:
Connors, JM
Ruddy, RM
McCall, J
Garcia, VF
Citation: Jm. Connors et al., Delayed diagnosis in pediatric blunt trauma, PEDIAT EMER, 17(1), 2001, pp. 1-4
Authors:
Christou, H
Connors, JM
Ziotopoulou, L
Hatzidakis, V
Papathanassoglou, E
Ringer, SA
Mantzoros, CS
Citation: H. Christou et al., Cord blood leptin and insulin-like growth factor levels are independent predictors of fetal growth, J CLIN END, 86(2), 2001, pp. 935-938
Authors:
Lohrisch, CA
Nevill, TJ
Barnett, MJ
Hogge, DE
Connors, JM
Keown, PA
Gascoyne, RD
Citation: Ca. Lohrisch et al., Development of a biologically distinct EBV-related lymphoproliferative disorder following autologous bone marrow transplantation for an EBV-negative post-renal allograft Burkitt's lymphoma, LEUK LYMPH, 39(1-2), 2000, pp. 195
Authors:
Weisenburger, DD
Gascoyne, RD
Bierman, PJ
Shenkier, T
Horsman, DE
Lynch, JC
Chan, WC
Greiner, TC
Connors, JM
Vose, JM
Armitage, JO
Sanger, WG
Citation: Dd. Weisenburger et al., Clinical significance of the t(14;18) and BCL2 overexpression in follicular large cell lymphoma, LEUK LYMPH, 36(5-6), 2000, pp. 513-523
Authors:
Toze, CL
Shepherd, JD
Connors, JM
Voss, NJ
Gascoyne, RD
Hogge, DE
Klingemann, HG
Nantel, SH
Nevill, TJ
Phillips, GL
Reece, DE
Sutherland, HJ
Conneally, EA
Barnett, MJ
Citation: Cl. Toze et al., Allografting for indolent lymphoid neoplasms, ANN ONCOL, 11, 2000, pp. 59-61
Authors:
Au, WY
Horsman, DE
Viswanatha, DS
Connors, JM
Klasa, RJ
Gascoyne, RD
Citation: Wy. Au et al., 8q24 translocations in blastic transformation of mantle cell lymphoma, HAEMATOLOG, 85(11), 2000, pp. 1225-1227
Authors:
Toze, CL
Shepherd, JD
Connors, JM
Voss, NJ
Gascoyne, RD
Hogge, DE
Klingemann, HG
Nantel, SH
Nevill, TJ
Phillips, GL
Reece, DE
Sutherland, HJ
Barnett, MJ
Citation: Cl. Toze et al., Allogeneic bone marrow transplantation for low-grade lymphoma and chronic lymphocytic leukemia, BONE MAR TR, 25(6), 2000, pp. 605-612
Authors:
Bennett, CL
Connors, JM
Moake, JL
Citation: Cl. Bennett et al., Clopidogrel and thrombotic thrombocytopenic purpura. Reply, N ENG J MED, 343(16), 2000, pp. 1193-1194
Authors:
Bennett, CL
Connors, JM
Carwile, JM
Moake, JL
Bell, WR
Tarantolo, SR
McCarthy, LJ
Sarode, R
Hatfield, AJ
Feldman, MD
Davidson, CJ
Tsai, HM
Citation: Cl. Bennett et al., Thrombotic thrombocytopenic purpura associated with clopidogrel., N ENG J MED, 342(24), 2000, pp. 1773-1777
Authors:
Brown, JA
Carson, BW
Gascoyne, RD
Cooperberg, PL
Connors, JM
Mason, AC
Citation: Ja. Brown et al., Low grade gastric MALT lymphoma: Radiographic findings, CLIN RADIOL, 55(5), 2000, pp. 384-389
Authors:
Connors, JM
O'Callaghan, MJ
Burns, YR
Gray, PH
Tudehope, DI
Mohay, H
Rogers, YM
Citation: Jm. Connors et al., The influence of growth on development outcome in extremely low birthweight infants at 2 years of age, J PAEDIAT C, 35(1), 1999, pp. 37-41
Authors:
Shariff, S
Yoshida, EM
Gascoyne, RD
Le, N
Connors, JM
Middleton, PJ
Shenkier, TN
Citation: S. Shariff et al., Hepatitis C infection and B-cell non-Hodgkin's lymphoma in British Columbia: A cross-sectional analysis, ANN ONCOL, 10(8), 1999, pp. 961-964
Authors:
Au, WY
Gascoyne, RD
Le, N
Viswanatha, DS
Klasa, RJ
Gallagher, R
Connors, JM
Citation: Wy. Au et al., Incidence of second neoplasms in patients with MALT lymphoma: No increase in risk above the background population, ANN ONCOL, 10(3), 1999, pp. 317-321
Authors:
Macpherson, N
Lesack, D
Klasa, R
Horsman, D
Connors, JM
Barnett, M
Gascoyne, RD
Citation: N. Macpherson et al., Small noncleaved, non-Burkitt's (Burkitt-like) lymphoma: Cytogenetics predict outcome and reflect clinical presentation, J CL ONCOL, 17(5), 1999, pp. 1558-1567
Authors:
Porter, DL
Connors, JM
Van Deerlin, VMD
Duffy, KM
McGarigle, C
Saidman, SL
Leonard, DGB
Antin, JH
Citation: Dl. Porter et al., Graft-versus-tumor induction with donor leukocyte infusions as primary therapy for patients with malignancies, J CL ONCOL, 17(4), 1999, pp. 1234-1243
Authors:
Cheson, BD
Horning, SJ
Coiffier, B
Shipp, MA
Fisher, RI
Connors, JM
Lister, TA
Vose, J
Grillo-Lopez, A
Hagenbeek, A
Cabanillas, F
Klippensten, D
Hiddemann, W
Castellino, R
Harris, NL
Armitage, JO
Carter, W
Hoppe, R
Canellos, GP
Citation: Bd. Cheson et al., Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas, J CL ONCOL, 17(4), 1999, pp. 1244-1253
Authors:
Skinnider, BF
Connors, JM
Sutcliffe, SB
Gascoyne, RD
Citation: Bf. Skinnider et al., Anaplastic large cell lymphoma: A clinicopathologic analysis, HEMATOL ONC, 17(4), 1999, pp. 137-148
Authors:
Reece, DE
Nevill, TJ
Sayegh, A
Spinelli, JJ
Brockington, DA
Barnett, MJ
Klingemann, HG
Connors, JM
Nantel, SH
Shepherd, JD
Sutherland, HJ
Voss, NJS
Fairey, RN
O'Reilly, SE
Phillips, GL
Citation: De. Reece et al., Regimen-related toxicity and non-relapse mortality with high-dose cyclophosphamide, carmustine (BCNU) and etoposide (VP16-213) (CBV) and CBV plus cisplatin (CBVP) followed by autologous stem cell transplantation in patients with Hodgkin's disease, BONE MAR TR, 23(11), 1999, pp. 1131-1138
Authors:
Cook, RC
Connors, JM
Gascoyne, RD
Fradet, G
Levy, RD
Citation: Rc. Cook et al., Treatment of post-transplant lymphoproliferative disease with rituximab monoclonal antibody after lung transplantation, LANCET, 354(9191), 1999, pp. 1698-1699
Authors:
Au, WY
Gascoyne, RD
Viswanatha, DS
Skinnider, BF
Connors, JM
Klasa, RJ
Horsman, DE
Citation: Wy. Au et al., Concurrent chromosomal alterations at 3q27, 8q24 and 18q21 in B-cell lymphomas, BR J HAEM, 105(2), 1999, pp. 437-440
Authors:
Gascoyne, RD
Aoun, P
Wu, D
Chhanabhai, M
Skinnider, BF
Greiner, TC
Morris, SW
Connors, JM
Vose, JM
Viswanatha, DS
Coldman, A
Weisenburger, DD
Citation: Rd. Gascoyne et al., Prognostic significance of anaplastic lymphoma kinase (ALK) protein expression in adults with anaplastic large cell lymphoma, BLOOD, 93(11), 1999, pp. 3913-3921
Authors:
Connors, JM
Yahalom, J
Noordijk, EM
Citation: Jm. Connors et al., Principles of combined-modality therapy in Hodgkin's disease, HODGKIN'S DISEASE, 1999, pp. 395-407
Authors:
Mauch, PM
Connors, JM
Pavlovsky, S
Duhmke, E
Citation: Pm. Mauch et al., Treatment of favorable prognosis, stage I-II Hodgkin's disease, HODGKIN'S DISEASE, 1999, pp. 435-458
Risultati:
1-25
|